Embecta (EMBC) Research & Development (2020 - 2026)
Embecta's (EMBC) quarterly Research & Development came in at $5.6 million in Q2 2026, up 27.27% year-over-year from $4.4 million in Q2 2025, and up 3.7% quarter-over-quarter from $5.4 million in Q1 2026.
Powered by 
Analysis
Embecta (EMBC) Research & Development (2020 - 2026) Analysis & Trends
Embecta has disclosed Research & Development across 7 years of filings, most recently posting $5.6 million for Q2 2026.
- In Q2 2026, Research & Development rose 27.27% year-over-year to $5.6 million; the TTM figure through Jun 2026 stood at $20.2 million (down 61.52% YoY), while the FY2025 annual figure was $37.3 million, down 52.66% from the prior year.
- Research & Development came in at $5.6 million for Q2 2026 at Embecta, up from $5.4 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $23.6 million in Q3 2023 to a low of $4.4 million in Q2 2025.
- Average Research & Development over 5 years is $14.8 million, with a median of $18.0 million recorded in 2022.
- Year-over-year, Research & Development surged 58.04% in 2023 and slumped 78.43% in 2025.
- Over 5 years, Research & Development stood at $16.9 million in 2022, then advanced by 19.53% to $20.2 million in 2023, then increased by 0.5% to $20.3 million in 2024, then plunged by 77.34% to $4.6 million in 2025, then increased by 21.74% to $5.6 million in 2026.
- Per Business Quant data, the three most recent Research & Development figures were $5.6 million in Q2 2026, $5.4 million in Q1 2026, and $4.6 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.18 Bn | 173.23 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Intuitive Surgical | 142.14 Bn | 137.06 Bn | 1.96 Bn | 370.60 Mn |
| 3 | Medtronic | 117.43 Bn | 109.23 Bn | 6.34 Bn | 771.00 Mn |
| 4 | Stryker | 105.15 Bn | 101.68 Bn | 4.50 Bn | 434.00 Mn |
| 5 | Boston Scientific | 63.37 Bn | 63.08 Bn | 3.85 Bn | 554.00 Mn |
| 6 | Edwards Lifesciences | 50.93 Bn | 46.79 Bn | 1.35 Bn | 278.90 Mn |
| 7 | Dexcom | 33.65 Bn | 31.71 Bn | 830.00 Mn | 153.00 Mn |
| 8 | Resmed | 32.27 Bn | 30.80 Bn | 861.22 Mn | 105.73 Mn |
| 9 | Alcon | 31.62 Bn | 30.17 Bn | 1.68 Bn | -663.00 Mn |
| 10 | Embecta | 300.30 Mn | 82.10 Mn | 153.30 Mn | 5.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.60 Mn |
| Mar 31, 2026 | 5.40 Mn |
| Dec 31, 2025 | 4.60 Mn |
| Sep 30, 2025 | 4.60 Mn |
| Jun 30, 2025 | 4.40 Mn |
| Mar 31, 2025 | 8.00 Mn |
| Dec 31, 2024 | 20.30 Mn |
| Sep 30, 2024 | 19.80 Mn |
| Jun 30, 2024 | 20.40 Mn |
| Mar 31, 2024 | 18.40 Mn |
| Dec 31, 2023 | 20.20 Mn |
| Sep 30, 2023 | 23.60 Mn |
| Jun 30, 2023 | 22.60 Mn |
| Mar 31, 2023 | 22.10 Mn |
| Dec 31, 2022 | 16.90 Mn |
| Sep 30, 2022 | 17.90 Mn |
| Jun 30, 2022 | 14.30 Mn |
| Mar 31, 2022 | 18.00 Mn |
| Dec 31, 2021 | 16.70 Mn |
| Sep 30, 2021 | 19.50 Mn |
API Access
Embecta Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=EMBC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "EMBC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=EMBC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();